Clinical Trial

NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the…

1 year ago

Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial

Trial to study Major Depressive Disorder using Optimi's GMP natural psilocybin capsules in conjunction with therapyVancouver, British Columbia--(Newsfile Corp. -…

1 year ago

Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer

LOS GATOS, CA / ACCESSWIRE / August 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a…

1 year ago

AI-based Medical Device Company Imidex and Precision Genomix Company Orbit Genomics Form Strategic Relationship to Explore the Detection of Lung Cancer in Early Stages

Computer Vision AI and Precision Genomic Collaboration Aims to Increase Early Detection Rates, Improving Survival Chances for Millions DENVER, Aug.…

1 year ago

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

BRENTWOOD, Tenn., Aug. 27, 2024 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax") today announced the results of a Cardiovascular Health Outcomes Analysis…

1 year ago

KORE and Social Mobile Collaborate on Mobility Solutions for Connected Health

ATLANTA, Aug. 27, 2024 /PRNewswire/ -- KORE, a global leader in Internet of Things ("IoT") solutions and pioneering IoT hyperscaler, and…

1 year ago

Nova Mentis Assigns Intellectual Property

Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)…

1 year ago

NervGen Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company…

1 year ago

Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Company invites shareholders and all interested parties to learn our journey for ultimately becoming AI's nose capable of digitizing smell.SAN…

1 year ago

PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection

Company provides update on regulatory progress towards US NDA submission TARRYTOWN, NY / ACCESSWIRE / August 27, 2024 / PaxMedica,…

1 year ago